Parmax Pharma Limited has rescheduled its Board of Directors meeting due to unavoidable reasons. The meeting, originally scheduled for an unspecified date, will now be held on Tuesday, June 02, 2026.
The primary agenda of the rescheduled board meeting is to consider and approve the Audited Financial Results for the Quarter and Financial Year ended March 31, 2026.
The trading window for dealing in the company's securities remains closed as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's Code to Regulate, Monitor and Report Trading by Insiders. The closure will continue up to forty-eight hours after the announcement of the Audited Financial Results for the Quarter/Financial Year ended March 31, 2026.